SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NVS: Novartis AG -- Ignore unavailable to you. Want to Upgrade?


To: Steve Becker who wrote (22)3/1/2001 11:22:42 AM
From: Starlight  Respond to of 116
 
Novartis files to get approval of leukemia drug:

biz.yahoo.com



To: Steve Becker who wrote (22)4/9/2001 12:45:28 AM
From: Starlight  Read Replies (1) | Respond to of 116
 
Glivec, the Novartis drug for leukemia, was featured on ABC's 20/20 Friday night, and it is getting a lot of attention on the ABC website:

abcnews.go.com

abcnews.go.com

The drug is also being tested on some other forms of cancer, and so far results have been very promising. I wonder how long it will take the investing community to start taking notice of this stock.